<DOC>
	<DOC>NCT00700999</DOC>
	<brief_summary>The purpose of this study is to examine if treatment of post-traumatic stress disorder in combat veterans with paroxetine changes brain responses as measured by functional magnetic resonance imaging and if brain responses can predict who will get better with treatment.</brief_summary>
	<brief_title>Brain Markers of Treatment Response in Post-Traumatic Stress Disorder (PTSD)</brief_title>
	<detailed_description />
	<mesh_term>Stress Disorders, Traumatic</mesh_term>
	<mesh_term>Stress Disorders, Post-Traumatic</mesh_term>
	<mesh_term>Paroxetine</mesh_term>
	<criteria>Veterans with clinical diagnosis of posttraumatic stress disorder from combat related to deployment to Afghanistan/Iraq (Operation Enduring Freedom/Operation Iraqi Freedom) Intolerance or sensitivity to paroxetine Major medical or neurologic illness Current psychotropic medication or active psychotherapy treatment Other major psychiatric illness</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>May 2014</verification_date>
</DOC>